renowned organization of professionals with a responsibility to innovate and
create the future, not wait for it. My colleagues and I prioritize collaboration--
teaming with experts throughout the North Shore-LIJ Health System and
other notable institutions--to produce knowledge necessary to cure disease.
We rely on each other as expert, steadfast, and collegial teammates--knowing
that together we will accomplish our goals.
The Feinstein Institute produced tremendous achievements in 2014 and 2015.
In 2014, Feinstein Institute investigators published new insights into how to
treat brain disorders in The Journal of Clinical Investigation, and a discovery
of new genes, pathways and cell types involved in inherited susceptibility to
rheumatoid arthritis in Nature. Kanti R. Rai, MD, an internationally-renowned
leukemia researcher and hematologist, was recognized by the American
Society of Hematology with the Society's highest honor, the 2014 Wallace H.
Coulter Award for Lifetime Achievement in Hematology. The Feinstein Institute
established collaborations with the University of Notre Dame, Natera, Inc., a
leader in non-invasive genetic testing and i360medical Ltd., an Irish medical device innovation company. Also in 2014, the
Feinstein Institute established the first Brain Tumor Biotech Center with Voices Against Brain Cancer. Molecular Medicine,
our peer-reviewed, open-access journal published its 20th anniversary edition. We announced a strategic affiliation to
align the world-class cancer research of Cold Spring Harbor Laboratory with our network of clinical services to accelerate
cancer research, diagnosis and treatment. Peter Davies, PhD, head of the Litwin-Zucker Research Center for the Study of
Alzheimer's Disease, received one of the highest honors in neurology, the American Academy of Neurology's Potamkin
Prize for Research in Pick's, Alzheimer's and Related Diseases. And we launched an important new strategic initiative to
lead the nascent field of bioelectronic medicine, an idea that was featured in the March issue of Scientific American.
With the strong foundation established over the past years and the extraordinary researchers here, the Feinstein Institute
is ideally and uniquely positioned for growth and continued success. This vision will be put into action with the support of
generous donors. So join us and witness firsthand the results of a brilliant collaboration dedicated to the noblest cause.
President and CEO
The Feinstein Institute for Medical Research
KEVIN J. TRACEY, MD